Clinical Trials Browser

Phase 2 × INDUSTRY × vorolanib × Clear all

NCT03848611 2020-07-09

CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03904719 2020-07-09

CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)

Phase 2 Unknown

Small Cell Lung Carcinoma